A newly developed technology draws on the latest genome editing advances to detect viruses at scale—including the one that causes coronavirus disease 2019 (COVID-19)—for surveillance and diagnostic purposes. The innovation, recently described in Nature, uses clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR–associated protein 13 (Cas13), gene editing tools based on a bacterial defense system against invading viruses.
Hampton T. Virus Surveillance and Diagnosis With a CRISPR-Based Platform. JAMA. 2020;324(5):430. doi:10.1001/jama.2020.12669
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: